TNF Antagonists

Links shared publicly online about this topic

TNF Antagonists and Peripheral Neuropathy - Pathophilia

bmartinmd.com — “TNF Antagonists and Peripheral Neuropathy - PathophiliaView full resource at bmartinmd.com

  • View Related
  • Share

Most Recently Shared on April 27, 2011 at 2:59 pm By:

Pathophilia Barbara J. Martin Physician, Doctor, and Neurologist

TNF Antagonists and Peripheral Neuropathy: A Montana woman is suing Abbott, the maker of Humira, after she devel... http://bit.ly/ftPXNR

10 months ago...

MedWire News - Dermatology - TNF antagonists have favorable benefit-risk profile for psoriasis

medwire-news.md — “MedWire News Tumor necrosis factor antagonists are more likely to be successful for the treatment of psoriasis during the initial year of treatment than they are to cause serious toxicity, quantitative benefit-risk assessment data show. MedWire NewsView full resource at medwire-news.md

  • View Related
  • Share

Most Recently Shared on May 15, 2010 at 9:06 pm By:

Psoriasis_OW Psoriasis OW OW Health

TNF antagonists have favorable benefit-risk profile for psoriasis: Tumor necrosis factor antagonists are more like... http://bit.ly/al3vay

2 years ago...

TNF Antagonist Therapy Reduces Cardiovascular Risk in RA Patients : Internal Medicine News

internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice treView full resource at internalmedicinenews.com

  • View Related
  • Share

Most Recently Shared on April 28, 2011 at 5:38 pm By:

MedicalNewsNet Bob Finn - Medical News Net Health News

TNF inhibitors associated w reduced cardiovascular risk in rheumatoid arthritis. A.R. Schonfeld reports. http://bit.ly/mKOmZA

9 months ago...

Journal of Investigative Dermatology - Abstract of article: TNF-[alpha] Downregulates Filaggrin and Loricrin through c-Jun N-terminal Kinase: Role for TNF-[alpha] Antagonists to Improve Skin Barrier

nature.com — “The Journal of Investigative Dermatology publishes basic and clinical research in cutaneous biology and skin disease.View full resource at nature.com

  • View Related
  • Share

Most Recently Shared on June 9, 2011 at 11:27 am By:

JuanCIvancevich Juan C. Ivancevich, MD Allergist, Physician, Doctor, and Internist

TNF-α antagonist results in significant enhancement of epidermal barrier protein expression http://bit.ly/lZaH1M

8 months ago...

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis -- Greenberg et al. 70 (4): 576 -- Annals of the Rheumatic Diseases

ard.bmj.com — “Greenberg, Jeffrey D; Kremer, Joel M; Curtis, Jeffrey R; Hochberg, Marc C; Reed, George; Tsao, Peter; Farkouh, Michael E; Nasir, Adeel; Setoguchi, Soko; Solomon, Daniel HView full resource at ard.bmj.com

  • View Related
  • Share

Most Recently Shared on March 16, 2011 at 8:08 pm By:

PsoriasisTx PsoriasisTx.com Health Site and Dermatology

#rheumatology | TNF inhibitiors reduce CV risk in patients with rheumatoid #arthritis. http://ow.ly/4fXsk

11 months ago...

How to Pick & Choose: Which Patient & Agent in Biologic-Naive Patients

hcplive.com — “The past decade has seen increased use of TNF antagonists for the treatment of inflammatory bowel disease.View full resource at hcplive.com

  • View Related
  • Share

Most Recently Shared on October 20, 2010 at 4:42 pm By:

HCPLive_Gastro HCPLive_GastroCMS de Gastroenterology

How to Pick & Choose: Which Patient & Agent in Biologic-Naive Patients -Feagan @ #ACG2010 -http://hcp.lv/c2r8iA

1 year ago...

Multiple Sclerosis - Rituximab Infusion: My First Experience

healthcentral.com — “On November 19th, I went to the local hospital outpatient infusion clinic to receive the first dose of Rituxan® (rituximab).  This Thursday I go back f...View full resource at healthcentral.com

  • View Related
  • Share

Most Recently Shared on December 1, 2009 at 10:50 pm By:

LisaEmrich Lisa Emrich Patient Expert

Rituximab Infusion: My First Experience: On November 19th, I went to the local hospital outpatient infusion clinic ... http://bit.ly/8FbGpH

2 years ago...

FDA Alert: Rituxan (rituximab) - PML

drugs.com — “FDA Alert: Rituxan (rituximab) - PMLView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on October 24, 2009 at 3:51 am By:

drugscom Drugs.com Health Site

FDA Alert - Rituxan (rituximab) - Third Case of PML Reported - http://bit.ly/2blHZY

2 years ago...

FDA Approves Actemra for the Treatment of Moderately to Severely Active Rheumatoid Arthritis

drugs.com — “Actemra (tocilizumab) is used to treat rheumatoid arthritis. Includes Actemra side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on January 12, 2010 at 12:27 am By:

drugscom Drugs.com Health Site

FDA Approves Actemra for the Treatment of Moderately to Severely Active Rheumatoid Arthritis - http://bit.ly/8vWion

2 years ago...

HCPLive | The preeminent online destination for tools, techniques, and information for healthcare professionals | Rheumatology | Biomarker Could Help Doctors Tailor Treatment for Rheumatoid Arthritis

hcplive.com — “Investigators have identified a biomarker that could help doctors selectView full resource at hcplive.com

  • View Related
  • Share

Most Recently Shared on January 29, 2010 at 3:55 pm By:

HCPLive_Pain HCPLive Pain Management

Biomarker Could Help Doctors Tailor Treatment for Rheumatoid Arthritis (http://bit.ly/cGXjbW) Interferon beta I predicts treatment response.

2 years ago...

FDA Alert: Rituxan (rituximab) - PML

drugs.com — “FDA Alert: Rituxan (rituximab) - PMLView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on October 24, 2009 at 2:10 pm By:

Rheumatology Article | Tumor Necrosis Factors

mdlinx.com — “Age at treatment predicts reason for discontinuation of TNF antagonists: Data from the BIOBADASER 2.0 registryView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on August 24, 2011 at 9:01 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Age at treatment predicts reason for discontinuation of TNF antagonists: Data from the BIOBADASER ... http://t.co/89QlSAe #Rheumatology

6 months ago...

Orencia Early Leader Among New Biologics To Treat Rheumatoid Arthritis

medicalnewstoday.com — “Sermo, the world's largest online community for physicians, announced a Sermo Event Report titled Is there any Threat to Anti-TNFs from Newer Biologic DMARDs? In the past year, the FDA has approView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 2, 2010 at 2:06 pm By:

mnt_arthritis MNT Arthritis News Health News

Orencia Early Leader Among New Biologics To Treat Rheumatoid Arthritis http://mnt.to/3zL8 #arthritis

2 years ago...

FDA Approves ACTEMRA(R) (tocilizumab) For The Treatment Of Moderately To Severely Active Rheumatoid Arthritis

medicalnewstoday.com — “Genentech, inc., a wholly owned member of the roche group (six: ro, rog; otcqx: rhhby), today announced that the u.s. food and drug administration (fda) approved actemra® (tocilizumab) for theView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 11, 2010 at 5:07 pm By:

mnt_arthritis MNT Arthritis News Health News

FDA Approves ACTEMRA(R) (tocilizumab) For The Treatment Of Moderately To Severely Active Rheumatoid Arthritis http://mnt.to/3w8r

2 years ago...

Rheumatology Medical News about adalimumab

mdlinx.com — “Treatment of relapsing polychondritis with the TNF-alpha antagonist adalimumabView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on June 16, 2010 at 4:25 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Treatment of relapsing polychondritis with the TNF-alpha antagonist adalimumab: Clinical Rheumatology http://bit.ly/bs9R9O #Rheumatology

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390